Squawk Pod cover image

5 Things to Know Before the Opening Bell 1/9/26

Squawk Pod

00:00

Merck in talks to buy Revolution Medicines

Andrew Ross Sorkin reports Merck is reportedly negotiating a $28–$32 billion acquisition of RevMed.

Play episode from 01:02
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app